300026 红日药业
2023/09 - 九个月2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)5.9897.7729.1848.2036.103
总资产报酬率 ROA (%)4.0675.1446.3096.1645.060
投入资产回报率 ROIC (%)4.7676.0747.4697.3005.810

边际利润分析
销售毛利率 (%)55.32957.72757.93356.54167.821
营业利润率 (%)11.02710.71511.41010.0829.659
息税前利润/营业总收入 (%)12.80811.57711.87211.4479.699
净利润/营业总收入 (%)10.4019.3388.7468.6268.164

收益指标分析
经营活动净收益/利润总额(%)90.207102.181121.848103.652129.341
价值变动净收益/利润总额(%)-0.0800.441-2.6910.2963.518
营业外收支净额/利润总额(%)8.6290.538-2.4604.2870.245

偿债能力分析
流动比率 (X)3.8782.7583.3072.4423.510
速动比率 (X)2.7361.9312.6731.8362.786
资产负债率 (%)28.25233.15431.4880.27416.095
带息债务/全部投入资本 (%)17.12220.58720.04114.4534.654
股东权益/带息债务 (%)475.503377.808391.990584.9222,025.092
股东权益/负债合计 (%)249.187197.508212.669258.061500.379
利息保障倍数 (X)17.31514.38316.13012.528595.412

营运能力分析
应收账款周转天数 (天)174.368186.193144.908130.465135.786
存货周转天数 (天)266.070225.278151.834147.432171.198